134 related articles for article (PubMed ID: 2142232)
1. In vitro and in vivo binding of toremifene and its metabolites in rat uterus.
Simberg NH; Murai JT; Siiteri PK
J Steroid Biochem; 1990 Jun; 36(3):197-202. PubMed ID: 2142232
[TBL] [Abstract][Full Text] [Related]
2. Binding of estrogen and antiestrogen in uterine cell nuclei: in vivo autoradiographic studies.
Ennis BW; Stumpf WE
J Steroid Biochem; 1988 Oct; 31(4A):405-9. PubMed ID: 3172774
[TBL] [Abstract][Full Text] [Related]
3. Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptors.
Martel C; Provencher L; Li X; St Pierre A; Leblanc G; Gauthier S; Mérand Y; Labrie F
J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):199-205. PubMed ID: 9605415
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
5. Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifen.
Kim J; Coss CC; Barrett CM; Mohler ML; Bohl CE; Li CM; He Y; Veverka KA; Dalton JT
Int J Cancer; 2013 Mar; 132(6):1475-85. PubMed ID: 22915089
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic localization of [3H]hydroxytamoxifen to uterine oestrogen- and antioestrogen-binding sites.
Ennis BW; Stumpf WE
Histochem J; 1989 Jan; 21(1):52-60. PubMed ID: 2745159
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of toremifene in the rat.
Sipilä H; Kangas L; Vuorilehto L; Kalapudas A; Eloranta M; Södervall M; Toivola R; Anttila M
J Steroid Biochem; 1990 Jun; 36(3):211-5. PubMed ID: 2142235
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical and genetic evidence for specific antiestrogen binding sites.
Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of progestin-binding sites in uterine cell types by estrogen and antiestrogen.
Ennis BW; Stumpf WE
Endocrinology; 1988 Oct; 123(4):1747-53. PubMed ID: 3416812
[TBL] [Abstract][Full Text] [Related]
10. The effects of diethylstilbestrol, tamoxifen, and toremifene on estrogen-inducible hepatic proteins and estrogen receptor proteins in female rats.
Kendall ME; Rose DP
Toxicol Appl Pharmacol; 1992 May; 114(1):127-31. PubMed ID: 1533964
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen.
Löser R; Seibel K; Roos W; Eppenberger U
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):985-90. PubMed ID: 4043181
[TBL] [Abstract][Full Text] [Related]
12. Rat uterine growth and induction of progesterone receptor without estrogen receptor translocation.
Jordan VC; Tate AC; Lyman SD; Gosden B; Wolf MF; Bain RR; Welshons WV
Endocrinology; 1985 May; 116(5):1845-57. PubMed ID: 3987619
[TBL] [Abstract][Full Text] [Related]
13. Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats.
Goss PE; Qi S; Hu H
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):233-40. PubMed ID: 19429427
[TBL] [Abstract][Full Text] [Related]
14. Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes.
Watanabe M; Watanabe N; Maruyama S; Kawashiro T
Drug Metab Pharmacokinet; 2015 Oct; 30(5):325-33. PubMed ID: 26423799
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of post-administration body distribution of toremifene and tamoxifen, and their administration regimens].
Masuoka H; Mori M; Nomura N; Sakurai M; Yoshida K; Usuda N; Shirai H; Shimokawara I; Asaishi K
Gan To Kagaku Ryoho; 2002 Jun; 29(6):881-7. PubMed ID: 12090039
[TBL] [Abstract][Full Text] [Related]
16. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
Wei LL; Mangel WF; Katzenellenbogen BS
J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
[TBL] [Abstract][Full Text] [Related]
17. Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.
Kawamura I; Lacey E; Tanaka Y; Nishigaki F; Manda T; Shimomura K
Jpn J Cancer Res; 1994 Jun; 85(6):639-44. PubMed ID: 8063618
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
di Salle E; Zaccheo T; Ornati G
J Steroid Biochem; 1990 Jun; 36(3):203-6. PubMed ID: 2142233
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic administration of mestranol, tamoxifen, and toremifene on hepatic ploidy in rats.
Dragan YP; Shimel RJ; Bahnub N; Sattler G; Vaughan JR; Jordan VC; Pitot HC
Toxicol Sci; 1998 Jun; 43(2):129-38. PubMed ID: 9710954
[TBL] [Abstract][Full Text] [Related]
20. Influence of different combinations of tamoxifen and toremifene on estrogen receptor-positive breast cancer cell lines.
Coradini D; Biffi A; Cappelletti V; Di Fronzo G
Cancer Detect Prev; 1995; 19(4):348-54. PubMed ID: 7553677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
